These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3019568)

  • 1. Specific transfer factor protects mice against lethal challenge with herpes simplex virus.
    Viza D; Vich JM; Phillips J; Rosenfeld F; Davies DA
    Cell Immunol; 1986 Jul; 100(2):555-62. PubMed ID: 3019568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nature and antigen-specific activities of transfer factor against herpes simplex virus type 1.
    Huang LL; Su CZ; Wan ZF
    Acta Virol; 1987 Nov; 31(6):449-57. PubMed ID: 2449810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression and enhancement of humoral antibody formation by herpes simplex virus types 1 and 2.
    Nick S; Kampe P; Knoblich A; Metzger B; Falke D
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1015-24. PubMed ID: 3011967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus.
    Zaia JA; Palmer EL; Feorino PM
    J Infect Dis; 1975 Dec; 132(6):660-6. PubMed ID: 172562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challenge.
    Ghiasi H; Roopenian DC; Slanina S; Cai S; Nesburn AB; Wechsler SL
    Immunology; 1997 Jul; 91(3):430-5. PubMed ID: 9301533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of in vivo depletion of immunocyte populations on herpes simplex virus glycoprotein D vaccine-induced resistance to HSV2 challenge.
    Mishkin EM; Blasiak M; Giorgio D; Ishizaka ST
    Viral Immunol; 1992; 5(2):151-61. PubMed ID: 1319710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
    Chan WL; Lukig ML; Liew FY
    J Exp Med; 1985 Oct; 162(4):1304-18. PubMed ID: 2995536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of subviral herpes simplex virus preparations: protection of mice against intraperitoneal infection with live virus.
    Kutinová L; Vonka V; Slichtová V
    Acta Virol; 1980 Dec; 24(6):391-8. PubMed ID: 6111199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response to type-common and type-unique epitopes of herpes simplex virus polypeptides.
    Bernstein DI; Bryson YJ; Lovett MA
    J Med Virol; 1985 Mar; 15(3):251-63. PubMed ID: 2580054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiidiotype modulation of herpes simplex virus infection leading to increased pathogenicity.
    Kennedy RC; Adler-Storthz K; Burns JW; Henkel RD; Dreesman GR
    J Virol; 1984 Jun; 50(3):951-3. PubMed ID: 6202879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative role of transplacental and milk immune transfer in protection against lethal neonatal herpes simplex virus infection in mice.
    Kohl S; Loo LS
    J Infect Dis; 1984 Jan; 149(1):38-42. PubMed ID: 6319505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S; Loo LS
    J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of antibody-dependent cellular cytotoxicity in neonatal infection with herpes simplex virus.
    Kohl S
    Rev Infect Dis; 1991; 13 Suppl 11():S950-2. PubMed ID: 1664132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of potent protection against acute and latent herpes simplex virus infection in mice vaccinated with dendritic cells.
    Ghasemi M; Erturk M; Buruk K; Sonmez M
    Cytotherapy; 2013 Mar; 15(3):352-61. PubMed ID: 23579060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baculovirus-expressed glycoprotein H of herpes simplex virus type 1 (HSV-1) induces neutralizing antibody and delayed type hypersensitivity responses, but does not protect immunized mice against lethal HSV-1 challenge.
    Ghiasi H; Kaiwar R; Nesburn AB; Wechsler SL
    J Gen Virol; 1992 Mar; 73 ( Pt 3)():719-22. PubMed ID: 1312127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of "modified-self"-induced specific antibody hyporesponsiveness to herpes simplex virus.
    Wilson LA; Thompson JJ; Ohkawa S; Scott DW
    Viral Immunol; 1992; 5(2):113-22. PubMed ID: 1377470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal analysis of T-cell responses to herpes simplex virus: isolation, characterization and antiviral properties of an antigen-specific helper T-cell clone.
    Leung KN; Nash AA; Sia DY; Wildy P
    Immunology; 1984 Dec; 53(4):623-33. PubMed ID: 6209206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity in vivo.
    Voss LM; David CS; Showalter SD; Paya CV; Leibson PJ
    Int Immunol; 1992 Mar; 4(3):417-20. PubMed ID: 1314641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.